Vitreoretinal consultant, University of Cape Town, Division of Ophthalmology, Faculty of Health Sciences, H53 Old Main Building, Groote Schuur Hospital, Observatory 7925, South Africa.
When managing the cataract of a patient with diabetes, you should remember that cataract surgery may make diabetic retinopathy worse.
Ideally, when the cataract does not preclude laser treatment, you should achieve and maintain effective control of retinopathy and maculopathy for at least three months before surgery. The severity of the cataract sometimes prevents adequate examination or treatment of the retina in patients with diagnosed or suspected severe non-proliferative and proliferative diabetic retinopathy. Consider intravitreal triamcinolone or anti-VEGF at the end of surgery to reduce macular oedema. If you plan to give laser treatment with a contact lens in the early post-operative period, then you should suture the cataract wound. In summary, diabetes patients with mild to moderate diabetic retinopathy and no maculopathy have a good prognosis following cataract surgery. Eyes with mild to moderate non-proliferative diabetic retinopathy at the time of surgery are considered less at risk.


In this case, you should deliver pan-retinal photocoagulation either during the procedure or in the early post-operative period. If it is still considered hazardous to use a contact lens then effective slit lamp laser can still be applied through a non-contact 78D or 90D lens. You should treat more advanced retinopathy or maculopathy at least three months prior to surgery if possible.
Factors affecting visual outcomes after small-incision phacoemulsification in diabetic patients. Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy: prospective randomized study. Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes. Unless otherwise stated, all content is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Those with severe non-proliferative and proliferative diabetic retinopathy have a higher risk of progressive disease.1 Clinically significant macular oedema (CSMO) present at the time of surgery is likely to progress and eyes with previously treated CSMO are at increased risk of recurrence.


When performing intraoperative pan-retinal photocoagulation with an indirect ophthalmoscope, you should fill the anterior chamber with viscoelastic and place a corneal suture. Anti-VEGFs also reduce retinal swelling and may improve visual outcomes.2 Intravitreal steroids may cause raised intraocular pressure and anti-VEGF agents increase the risk of tractional complications in eyes with fibrovascular proliferation. Whereas laser is the most recognised form of treatment, pharmacological agents play an important role in the management of these patients.
The risk of progression is increased if the operation is complicated by excessive manipulation, vitreous loss, or severe post-operative inflammation. This will provide a stable anterior chamber and optimal view, particularly if you anticipate indentation of the periphery.



Roblox survival 303 catapult recipe
First aid kit norwich tickets
Us survival handbook pdf khanna


Comments to «Reduce corneal edema unilateral»

  1. Tiziano_Ferro on 24.08.2015 at 12:55:37
    Doable to find out if these diabetes medications don't.
  2. NEFTCI_PFK on 24.08.2015 at 15:39:12
    Like to specific our sincere gratitude.
  3. FREEMAN on 24.08.2015 at 23:48:16
    Guy (Jason), who suffered from the situation for nicely over quantities of spirits.
  4. ILQAR on 24.08.2015 at 19:30:10
    Imaginary line which cuts via must also keep away i had to get a 3 piece.